w

YRAX

Pl{ARMXT

5T

SWRAX

PHARMA

PRIVATE

LIMITED

Styrax Pharma

Private

Limited

manufacturing

Active Pharmaceutical

Ingredients,

we

are focused

on the following

steps

to reducing

API

in Environment

(PiE)

through

minimization

of API residue/losses

in wastewater

streams.

#

,#

#

Adopting

Mass

balance

approach.

Periodic

review

of

the manufacturing

process

to

estimate

API losses

(account

for

batch

and cleaning

cycles)

Periodic

review

of the

manufacturing process

to improve yield

so that

loss

of

product

in

the effluent

can

be avoided.

Eliminate

direct

sewer discharges

of

rejected/spilled

material.

Use

dry cleaning

practices

as

much

as

practical

with

appropriate

disposal.

Minimize

equipment

rinse

discharge.

Shall meet

environment

protection

stafutory

requirements.

Shall increase

environmental

awareness

among

company

employees

and contract

workmen

and all

stakeholders.

Complies

the API

concentration in

discharge

less

than Predicted-No-Effect-

Concentration

(PNEC).

Managing

Director.

01st

January

2022

#

#

,#

#

d

#

{

I

POUCY